• Login
    View Item 
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    •   Home
    • The Manchester Institute Cancer Research UK
    • All Paterson Institute for Cancer Research
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Cd133: a marker of transit amplification rather than stem cell phenotype in the prostate?

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Grey, Benjamin R
    Oates, Jeremy E
    Brown, Michael D
    Clarke, Noel W
    Affiliation
    Genito-Urinary Cancer Research Group, University of Manchester Paterson Institute for Cancer Research, Manchester, UK. bengrey@doctors.org.uk
    Issue Date
    2009-04
    
    Metadata
    Show full item record
    Citation
    Cd133: a marker of transit amplification rather than stem cell phenotype in the prostate? 2009, 103 (7):856-8 BJU Int.
    Journal
    BJU International
    URI
    http://hdl.handle.net/10541/67946
    DOI
    10.1111/j.1464-410X.2008.08250.x
    PubMed ID
    19076138
    Language
    en
    ISSN
    1464-410X
    ae974a485f413a2113503eed53cd6c53
    10.1111/j.1464-410X.2008.08250.x
    Scopus Count
    Collections
    All Paterson Institute for Cancer Research
    Urological Oncology
    School of Cancer and Imaging Sciences

    entitlement

    Related articles

    • CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate.
    • Authors: Yamamoto H, Masters JR, Dasgupta P, Chandra A, Popert R, Freeman A, Ahmed A
    • Issue date: 2012
    • Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
    • Authors: Rentala S, Mangamoori LN
    • Issue date: 2010
    • Prominin1 (CD133) as an intestinal stem cell marker: promise and nuance.
    • Authors: Montgomery RK, Shivdasani RA
    • Issue date: 2009 Jun
    • Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
    • Authors: Zhou J, Wang H, Cannon V, Wolcott KM, Song H, Yates C
    • Issue date: 2011 Sep 14
    • CD133 as a marker for cancer stem cells: progresses and concerns.
    • Authors: Wu Y, Wu PY
    • Issue date: 2009 Oct
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.